Synopsys is the clear stand-alone way to play an Intel turnaround. The picture is less certain once Tesla's involvement with Intel is factored in, since Tesla uses Cadence. x.comÂ
Say No To Trading
Public Markets Investor, Opportunistic Buying & Cost-Basis Management
Demand for chip-design software is booming, making Synopsys the chip-design name to own after Cadence's results. Cadence reported a record $8.2 billion backlog and raised its 2026 revenue-growth outlook to 21%; Synopsys is still about 12% below its May high, and all four models signal Long on Synopsys versus Flat on Cadence. x.comÂ
Intel's weak guidance undermines the turnaround bet. The whole turnaround now looks like a scam, though the view will be reassessed later. x.com x.comÂ
LLM-driven hardware verification is generally bearish for Synopsys and Cadence, but not predictably enough in the short term to justify betting against them. A post being answered argues verification is the cleanest monetization path for the new LLM capability, with private math pure plays Harmonic and Axiom Math likely to target it, so sentiment on both should worsen. The development is broadly bullish for compute. x.comÂ
Synopsys's OpenAI deal and investor day have blown up the bear case that frontier AI will disrupt chip-design software. When OpenAI has dominant leverage over a partner, as with Cerebras, it extracts big equity concessions; it did not with Synopsys. KeyBanc called the investor day perfectly executed, citing much better than expected initial FY27 guidance, higher long-term EDA and IP targets, margin expansion and new AWS and OpenAI partnerships, and raised its target while reiterating Overweight. … Show more
Synopsys and Cadence benefit as AI shifts from general-purpose to specific-purpose models, a transition moving unusually fast and a sign this is a continuation of the buildout rather than a new cycle. Synopsys and OpenAI signed a multi-year deal to build GPT-Synopsys, a model that runs Synopsys EDA tools for tasks like timing closure and verification, with shared revenue. Synopsys also announced a multi-year, $1B+ silicon IP agreement with Amazon, showing what EDA players' IP can be used for. … Show more
Synopsys and Cadence face a net competitive negative if large chip designers build custom verification tools in-house, taking share of the largest slice of the EDA workflow. The market will likely sell the incumbents as this gets digested. Offsetting that, faster time to market is becoming table stakes, raising both the value of agentic design tools and the cost of failure. @lokoyacap counters that nothing shows EDA being made unnecessary and that it supports pricier AI-enabled seats. x.com … Show more
Cadence's IBD composite and EPS ratings of 90 support its standing as arguably the best in the 'making chips better' group after ASML. The screen estimates 2026 EPS growth of 18% and sales growth of 21%. Its chart is near a breakout after a long pullback. x.comÂ
Synopsys still works as a long against a short in the IGV software ETF, which hedges its two big issues: losing share at Intel to Cadence, and being software, which the market currently hates as a factor. x.comÂ
Synopsys and Cadence are shorts while ASIC design houses Global Unichip and Alchip are longs, because hyperscalers are taking chip IP design in-house. Synopsys design IP income fell 48% in Q1 to $66.1M, yet EDA trades near 70x earnings after losing China. Megacap seat counts are flat to down as AI makes engineers 2-3x more productive; Google TPU, AWS Trainium and other ASICs sold Cadence no new seats. Global Unichip revenue is up 60%, and Alchip, working on Trainium, is the highest-beta long. … Show more
AI should expand Cadence's market as pressure on silicon multiplies the companies designing custom chips, and every chip design startup uses its tools. EDA has risen from 7% to 11% of semiconductor R&D, and Cadence's CEO says AI agents run far more base-tool iterations, lifting usage. Moats are deep, as fabs must certify tools over years. The risk is that its few, highly savvy customers use AI to replace parts of the workflow, and it is tied to chips designed, not to inference spend. x.comÂ